Modelling the Impact of Social Distancing and Targeted Vaccination on the Spread of COVID-19 Through a Real City-Scale Contact Network

Published in: Journal of Complex Networks, Volume 9, Issue 6 (December 2021). doi: 10.1093/comnet/cnab042

Posted on RAND.org on December 15, 2021

by Gavin S. Hartnett, Edward Parker, Timothy R. Gulden, Raffaele Vardavas, David Kravitz

Read More

Access further information on this document at Journal of Complex Networks

This article was published outside of RAND. The full text of the article can be found at the link above.

We use mobile device data to construct empirical interpersonal physical contact networks in the city of Portland, Oregon, both before and after social distancing measures were enacted during the COVID-19 pandemic. These networks reveal how social distancing measures and the public's reaction to the incipient pandemic affected the connectivity patterns within the city. We find that as the pandemic developed there was a substantial decrease in the number of individuals with many contacts. We further study the impact of these different network topologies on the spread of COVID-19 by simulating an SEIR epidemic model over these networks and find that the reduced connectivity greatly suppressed the epidemic. We then investigate how the epidemic responds when part of the population is vaccinated, and we compare two vaccination distribution strategies, both with and without social distancing. Our main result is that the heavy-tailed degree distribution of the contact networks causes a targeted vaccination strategy that prioritizes high-contact individuals to reduce the number of cases far more effectively than a strategy that vaccinates individuals at random. Combining both targeted vaccination and social distancing leads to the greatest reduction in cases, and we also find that the marginal benefit of a targeted strategy as compared to a random strategy exceeds the marginal benefit of social distancing for reducing the number of cases. These results have important implications for ongoing vaccine distribution efforts worldwide.

Research conducted by

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/principles.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.